Ariadne Provides Pathway Studio® Interoperability with Illumina’s New GenomeStudio Software
December 29, 2008
ROCKVILLE, MD, December 29, 2008 – Ariadne announces the completion of a key partner program with Illumina Inc., to provide advanced integration and interpretation capabilities for data generated from their iScan and BeadArray Reader platforms. The coupling of Ariadne’s Pathway Studio® to Illumina’s next generation software, GenomeStudio™ Data Analysis Software, provides researchers with a state-of-the-art [...]
December 29, 2008
REHOVOT, Israel, JERSEY CITY, New Jersey and PHILADELPHIA, Pennsylvania, December 29 -- Rosetta Genomics, Ltd. (NASDQ: ROSG), the leading developer of microRNA-based molecular diagnostics, announced today the introduction of its third diagnostic test, miRview(TM) meso. The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia. To order the test, physicians may contact [...]
December 29, 2008
Celera Corporation (NASDAQ:CRA) and Abbott (NYSE:ABT) today announced a revision of the strategic alliance agreement between the two companies. Under a new distribution agreement, Abbott will exclusively distribute certain molecular diagnostic products manufactured by Celera. Under a second agreement, Celera will receive royalties on the sale of m2000™ reagents, instruments, service and related consumables, and [...]
FDA Signs Contract with Entelos to Predict Cardiovascular Adverse Events
December 26, 2008
Foster City, CA, December 16, 2008 - Entelos, Inc. (LSE: ENTL), the leader in predictive disease simulation for pharmaceutical, health-care and consumer products applications, today announced that it has entered into an agreement with the U.S. Food and Drug Administration (FDA) to use the Entelos® Cardiovascular PhysioLab® to assess the cardiovascular safety and efficacy of [...]
Advanced Photonix, Inc. Announces New Terahertz Development Contracts
December 23, 2008
Advanced Photonix, Inc.(R) (NYSE Alternext US: API) announced today that its subsidiary, Picometrix, LLC, has been selected to received a Phase II SBIR contract from NASA and a Phase I SBIR contract from the Air Force for nondestructive testing (NDT) application development utilizing the T-Ray(TM) 4000. Combined the contracts total $700,000 The NASA Phase II [...]
WuXi AppTec Selects H-Cube(R) from ThalesNano for Laboratory-based Hydrogenation
December 23, 2008
SHANGHAI, China, Dec. 23 /PRNewswire-Asia/ -- WuXi AppTec, the operating company of WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced its selection of H-Cube(R) from ThalesNano Inc. for laboratory-based hydrogenation. WuXi thus joins all the top 20 [...]
Thermo Fisher Scientific Headed To Mars With NASA
December 23, 2008
Thermo Fisher Scientific Inc., the world leader in serving science, recently announced that the Thermo Scientific Orion 229918 sensor assembly is part of the Wet Chemistry Laboratory (WCL) in NASA's Phoenix Mars Mission launched from Cape Canaveral on August 4, 2007. Under contract with NASA's Jet Propulsion Laboratory in Pasadena, California, the water specialists at [...]
Thermo Fisher Scientific Ohio Facility Wins Industry Week Magazines Best Plant Award
December 23, 2008
Marietta Facility Singled Out for Performance, Safety Record and Employee Excellence WALTHAM, Mass.--Thermo Fisher Scientific Inc. (NYSE: TMO - News), the world leader in serving science, today announced that its Marietta, Ohio, plant is a winner of Industry Week magazine’s 2008 Best Plant competition, which recognizes North American facilities for manufacturing excellence. The Marietta facility [...]
Volcano Announces Acquisition of Axsun Technologies, Inc.
December 23, 2008
TRANSACTION WILL ADVANCE OCT PRODUCT DEVELOPMENT PROGRAMS AND EXPAND CORE TECHNOLOGY AND REVENUE OPPORTUNITIES SAN DIEGO, Dec. 23 -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it has entered into a definitive agreement to [...]
Pressure BioSciences, Inc. and Battelle Memorial Institute Sign Exclusive Patent License Agreement
December 22, 2008
SOUTH EASTON, Mass., Dec. 22 -- Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI" or the "Company") today announced that they have entered into an exclusive patent license agreement with the Battelle Memorial Institute ("Battelle"). The licensed technology is described in the patent application filed by Battelle on July 31, 2008 (US serial number 12/183,219). This application [...]

